Yiu‐Lam Kwan

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood · 2014 · 623 citations · Full text

Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activity

T. Diamond, S. Levy, Peter Day et al. · British Journal of Haematology · 1997 · 71 citations · Full text

Glucocorticoid Therapy, Immunology, Pathology +20

Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn’s disease

Neil Moran, Bradley R. Webster, Kenneth Lee et al. · World Journal of Gastroenterology · 2015 · 64 citations · Full text

Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma

Sabna Rajeev Krishnan, Frederick Luk, Ross Brown et al. · Neoplasia · 2016 · 63 citations · Full text

An Open-Label, Randomized Study of Bendamustine and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL): The Bright Study

Ian W. Flinn, Richard H. van der Jagt, Brad S. Kahl et al. · Blood · 2012 · 32 citations